Navitoclax inhibits senescence in human alveolar type 2 cells from COPD patients

Yiling Guo; Peter Fenwick; Patrizia Viola; May Al‐Sahaf; Peter J Barnes; Louise Donnelly

doi:10.1183/13993003.congress-2024.pa897

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2024

Navitoclax inhibits senescence markers in precision cut lung slices from COPD patients

Peter Fenwick, Justine Devulder, May Al‐Sahaf, Patrizia Viola, Peter J Barnes, Louise Donnelly

Article2021

Alveolar type II cells harbouring SARS-CoV-2 show senescence with a proinflammatory phenotype

Koralia Paschalaki, Konstantinos Evangelou, Dimitris Veroutis, Periklis Foukas, Christos Kittas, Athanasios G. Tzioufas, Laurence de Leval, Demetris Vassilakos, Peter J Barnes, Vassilis G. Gorgoulis

Article2022

Inhaled corticosteroids reduce senescence in endothelial progenitor cells from patients with COPD

Koralia Paschalaki, Christos Rossios, Charis Pericleous, Mairi Macleod, Stephen Rothery, Gavin C. Donaldson, Jadwiga A. Wedzicha, Vassilis G. Gorgoulis, Anna M. Randi, Peter J Barnes

Article2025

BCLXL-PROTAC as a senolytic therapy in COPD alveolar type II cells

Yiling Guo, Peter Fenwick, Louise Donnelly, Peter J Barnes

Article2022

Extracellular vesicles produced by airway epithelial cells from COPD patients contain miRNAs involved in cellular senescence

Justine Devulder, Jonathan Baker, Susan J. Monkley, Lina Odqvist, Louise Donnelly, Peter J Barnes